Indication

Alpha-mannosidosis

Alpha-mannosidosis is an ultra-rare, inherited lysosomal storage disorder caused by pathogenic variants in the *MAN2B1* gene, resulting in a deficiency of the enzyme lysosomal alpha-mannosidase. Read more about Alpha-mannosidosis

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Alpha-mannosidosis therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Alpha-mannosidosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Alpha-mannosidosis.

Alpha-mannosidosis is an ultra-rare, inherited lysosomal storage disorder caused by pathogenic variants in the *MAN2B1* gene, resulting in a deficiency of the enzyme lysosomal alpha-mannosidase.

This enzymatic deficit leads to progressive, pathologic accumulation of mannose-rich oligosaccharides across tissues and organ systems.

Primarily presenting in pediatric patients and persisting into adulthood, the condition exhibits a spectrum of severity that can involve intellectual disability, sensorineural hearing loss, dysmorphic facial features, skeletal abnormalities (dysostosis multiplex), motor dysfunction, and immune deficiency with recurrent infections.

Personalize your experience

Follow Alpha-mannosidosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it